Delisting riskPopularity #3,932
Oncolytics Biotech (ONCY)
Develops pelareorep, a double-stranded RNA immunotherapy for gastrointestinal tumors.
$0.6769
vs last close−0.04 (−5.10%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
in 49 days
EPS estimate
−$0.07
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.07−$0.06−$0.05−$0.10−$0.01−$0.08−$0.08Pending
Estimate−$0.08−$0.09−$0.11−$0.12−$0.06−$0.05−$0.05−$0.07
Surprise+12.5%+33.3%+54.5%+16.7%+83.1%−60.0%−48.7%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.07 | — | — |
| Sep 2027 | −$0.06 | — | — |
| Jun 2027 | −$0.06 | — | — |
| Mar 2027 | −$0.05 | — | — |
| Dec 2026 | −$0.08 | — | — |
| Nov 2026 | −$0.07 | — | — |
| Aug 2026 | −$0.05 | −$0.08 | −48.7% |
| May 2026 | −$0.05 | −$0.08 | −60.0% |
| Mar 2026 | −$0.06 | −$0.01 | +83.1% |
| Nov 2025 | −$0.12 | −$0.10 | +16.7% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.07 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.06 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.06 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.05 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.08 | — | — | $0 | — | — | — |
| Nov 11, 2026 | −$0.07 | — | — | $0 | — | — | — |
| Aug 12, 2026 | −$0.05 | −$0.08 | −48.7% | — | — | — | +0.5% |
| May 14, 2026 | −$0.05 | −$0.08 | −60.0% | — | — | — | −2.6% |
| Mar 30, 2026 | −$0.06 | −$0.01 | +83.1% | — | — | — | −4.2% |
| Nov 12, 2025 | −$0.12 | −$0.10 | +16.7% | — | — | — | +5.6% |
| Aug 8, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 7, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 7, 2024 | |||||||
| Nov 3, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 5, 2023 | |||||||
| Mar 3, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 3, 2022 | |||||||
| Nov 5, 2021 | |||||||
| Aug 6, 2021 | |||||||
| May 7, 2021 | |||||||
| Mar 5, 2021 | |||||||
| Nov 11, 2020 | |||||||
| Aug 4, 2020 | |||||||
| May 8, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 13, 2019 | |||||||
| May 2, 2019 | |||||||
| Mar 8, 2019 | |||||||
| Nov 12, 2018 | |||||||
| Aug 3, 2018 | |||||||
| May 11, 2018 | |||||||
| Mar 9, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 3, 2017 | |||||||
| May 5, 2017 | |||||||
| Mar 10, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 6, 2016 | |||||||
| Mar 11, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 6, 2015 |